Shareholder alert: robbins llp is investigating athenex, inc. (atnx) for shareholders

San diego, calif. & buffalo, n.y.--(business wire)---- $atnx #breastcancer--athenex, inc. (atnx) misstated the efficacy of its lead drug candidate and the likelihood the fda would approve its new drug application

ATNX Ratings Summary

ATNX Quant Ranking